Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
University of Denver Alzheimer’s researcher Lotta Granholm-Bentley, PhD, DDS, is playing a key role in her community’s medical response to the coronavirus, and working with Colorado seniors to help combat the sense of isolation many are feeling during these difficult times.
As the global coronavirus pandemic began to hit our nation, University of Kentucky Alzheimer’s researcher Donna M. Wilcock, PhD and her team wanted to do something to help their community address the shortage of medical supplies hindering the local response.
Gains in life expectancy have been accompanied by a rise in age-related diseases, including Alzheimer’s disease, macular degeneration, and glaucoma. Geroscience, as a field, wants to reduce age-related diseases, and BrightFocus is excited about partnering with this interdisciplinary field. .
This publication provides information on what glaucoma is, the various forms of glaucoma, tips for lowering risk, how this eye disease is diagnosed and treated, and essential questions to ask your doctor after a diagnosis.
The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration. View the transcript Print the transcript Listen to the discussion:
UCLA Health This telephone discussion features Michael B. Gorin, MD, PhD, an ophthalmologist from UCLA who is devoted to research and clinical care of hereditary retinal disorders, especially age-related macular degeneration, retinal dystrophies and other medical retinal conditions. View the transcript Print the transcript Listen to the discussion:
BrightFocus Foundation held a virtual town hall on COVID-19 and older adults. Topics included long-distance caregiving, telehealth, social isolation, anxiety, and other issues disproportionately affecting aging adults. Please share this with a friend or family member.
May 19, 2020
Coronavirus & AMD: Your Questions Answered
Learn some helpful tips provided by UCLA ophthalmologist, Michael Gorin, MD, PhD.
BrightFocus Foundation, a nonprofit organization funding scientific research and promoting public awareness to end Alzheimer’s, macular degeneration, and glaucoma, today announced Shawna Gottlieb and Tonya M. Matthews, PhD, as new members of its Board of Directors.
BrightFocus Foundation is partnering with the National Institute of Health’s (NIH’s) National Institute of Neurological Disorders and Stroke (NINDS) to fund an innovative research grant to develop retinal scans to identify early signs of vascular contributions to cognitive dementia (VCID), one of the leading causes of memory loss.
A BrightFocus Foundation-funded project to develop a blood-based screening test for Alzheimer’s disease has passed proof of concept stage and C2N Diagnostics, the company spearheading the development of the test, will move forward to approve use in research and clinical settings, according to a presentation at a major scientific conference.
BrightFocus Foundation today announced that it has received a SHORTY Social Good Award® for the public impact of its nationwide screening tour of Turning Point, a documentary by acclaimed filmmaker James Keach.